NCT04205097View on ClinicalTrials.gov

Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

December 2, 2020

Study Completion Date

December 2, 2020

Conditions
Gastric Cancer
Interventions
DRUG

Neostigmine + glycopyrate

maintaining of moderate neuromuscular block (train-of-four count 1-2) during surgery, reversal using neostigmine 50 ug/kg and glycopyrrolate 10 ug/kg

DRUG

Sugammadex

maintaining of deep neuromuscular block (posttetanic count 1-2) during surgery, reversal using sugammadex 2-4 mg/kg

Trial Locations (1)

16499

Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT04205097 - Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy | Biotech Hunter | Biotech Hunter